School of Medicine
Showing 71-77 of 77 Results
Frank E. Stockdale
Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus
Current Research and Scholarly Interests Laboratory and clinical research in breast cancer ; Normal and abornal differentiation and growth
Melinda L. Telli, M.D.
Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
Haluk Tezcan, MD
Adjunct Clinical Assistant Professor, Medicine - Oncology
Bio Clinical focus:
Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.
He is leading the development of Lexent Bio's liquid biopsy technology, first in response monitoring, overseeing scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director both in academia and private practice, he has firsthand understanding of unmet clinical needs of physicians and patients, and broad experience in clinical trial design and implementation.
He established the CA.RE.foundation, a cancer research foundation dedicated to enabling clinical trial execution across community oncology sites throughout the Northwest US. He?s independently built multiple software tools to help oncologists in the practical realities of their daily work.
Before Lexent Bio, he has served as Director of Translational Medicine at Genomic Health and as Vice President leading oncology development at Counsyl, integrating science with clinical product development. He is a steering committee member of the ASCO QOPI, a quality care initiative.
Instructor, Medicine - Oncology
Current Research and Scholarly Interests Study of biological mechanism and dynamics (especially Tumor microenvironemtn) by intravital imaging;
Development of nanomedicines for diagnosis and therapy;
Understanding of nano-bio interaction
Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Wakelee's research is focused on clinical trials and translational efforts in patients with lung cancer and other thoracic malignancies such as thymoma and thymic carcinoma. Other interests include translation projects in thoracic malignancies and collaborations with population scientists regarding lung cancer questions.
Instructor, Medicine - Oncology
Bio Dr. Xia is a hybrid computer scientist, statistician and bioinformatician who takes a general interest in genome sciences and medicine. His career goal is to advance the field of precision health, in particular precision cancer medicine, by integrating novel technology, big-data, and intelligent models. Dr. Xia worked extensively on microbiome and human multiomics data modeling and analysis. His publications addressed many methodological needs in commensal bacteria, structural variation, and cancer genomics analysis. He and his works were recognized by the career awards he received from the American Cancer Society and the Innovation in Cancer Informatics Fund. Find out more about his research at https://profiles.stanford.edu/lixia.